UBS Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-35,053
| Closed | -$8.61M | – | 10253 |
|
|
2022
Q3 | $8.61M | Sell |
35,053
-12,164
| -26% | -$2.99M | ﹤0.01% | 1381 |
|
|
2022
Q2 | $11.7M | Buy |
47,217
+11,432
| +32% | +$2.83M | ﹤0.01% | 1250 |
|
|
2022
Q1 | $11.9M | Sell |
35,785
-1,284
| -3% | -$425K | ﹤0.01% | 1350 |
|
|
2021
Q4 | $13.3M | Buy |
37,069
+8,599
| +30% | +$3.09M | ﹤0.01% | 1358 |
|
|
2021
Q3 | $9.27M | Sell |
28,470
-6,989
| -20% | -$2.27M | ﹤0.01% | 1551 |
|
|
2021
Q2 | $11.1M | Sell |
35,459
-4,039
| -10% | -$1.26M | ﹤0.01% | 1443 |
|
|
2021
Q1 | $12.6M | Buy |
39,498
+9,402
| +31% | +$3M | ﹤0.01% | 1300 |
|
|
2020
Q4 | $9.76M | Sell |
30,096
-19,835
| -40% | -$6.43M | ﹤0.01% | 1407 |
|
|
2020
Q3 | $13.8M | Buy |
49,931
+11,806
| +31% | +$3.27M | 0.01% | 1111 |
|
|
2020
Q2 | $9.21M | Buy |
38,125
+17,274
| +83% | +$4.17M | ﹤0.01% | 1230 |
|
|
2020
Q1 | $3.03M | Buy |
20,851
+9,297
| +80% | +$1.35M | ﹤0.01% | 1852 |
|
|
2019
Q4 | $1.97M | Sell |
11,554
-12,834
| -53% | -$2.19M | ﹤0.01% | 2775 |
|
|
2019
Q3 | $4.34M | Sell |
24,388
-15,114
| -38% | -$2.69M | ﹤0.01% | 1966 |
|
|
2019
Q2 | $10.3M | Sell |
39,502
-20,832
| -35% | -$5.43M | ﹤0.01% | 1368 |
|
|
2019
Q1 | $17.2M | Buy |
60,334
+9,491
| +19% | +$2.71M | 0.01% | 1004 |
|
|
2018
Q4 | $16.5M | Sell |
50,843
-36,882
| -42% | -$12M | 0.01% | 944 |
|
|
2018
Q3 | $39.5M | Buy |
87,725
+5,741
| +7% | +$2.58M | 0.02% | 629 |
|
|
2018
Q2 | $33.5M | Buy |
81,984
+15,213
| +23% | +$6.22M | 0.01% | 681 |
|
|
2018
Q1 | $19.4M | Buy |
66,771
+6,740
| +11% | +$1.96M | 0.01% | 928 |
|
|
2017
Q4 | $11.3M | Sell |
60,031
-603
| -1% | -$113K | ﹤0.01% | 1264 |
|
|
2017
Q3 | $10.2M | Buy |
60,634
+16,323
| +37% | +$2.75M | ﹤0.01% | 1256 |
|
|
2017
Q2 | $6.35M | Buy |
44,311
+2,343
| +6% | +$336K | ﹤0.01% | 1504 |
|
|
2017
Q1 | $5.25M | Sell |
41,968
-14,782
| -26% | -$1.85M | ﹤0.01% | 1614 |
|
|
2016
Q4 | $6.4M | Buy |
56,750
+4,668
| +9% | +$526K | ﹤0.01% | 1419 |
|
|
2016
Q3 | $6.7M | Buy |
52,082
+5,081
| +11% | +$653K | ﹤0.01% | 1335 |
|
|
2016
Q2 | $5.14M | Buy |
47,001
+22,075
| +89% | +$2.41M | ﹤0.01% | 1491 |
|
|
2016
Q1 | $2.36M | Sell |
24,926
-1,086
| -4% | -$103K | ﹤0.01% | 2028 |
|
|
2015
Q4 | $2.35M | Buy |
26,012
+5,108
| +24% | +$461K | ﹤0.01% | 2065 |
|
|
2015
Q3 | $1.94M | Buy |
20,904
+12,629
| +153% | +$1.17M | ﹤0.01% | 2169 |
|
|
2015
Q2 | $544K | Buy |
8,275
+896
| +12% | +$58.9K | ﹤0.01% | 3206 |
|
|
2015
Q1 | $528K | Buy |
7,379
+171
| +2% | +$12.2K | ﹤0.01% | 3191 |
|
|
2014
Q4 | $275K | Buy |
+7,208
| New | +$275K | ﹤0.01% | 3561 |
|